Glycogenin (GYG) Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Acarbose | 56180-94-0 | sc-203492 sc-203492A | 1 g 5 g | $222.00 $593.00 | 1 | |
This inhibits alpha-glucosidase enzymes in the intestines, affecting carbohydrate digestion and absorption, which can indirectly impact glycogen synthesis. | ||||||
CP-91149 | 186392-40-5 | sc-396026A sc-396026 sc-396026B sc-396026C sc-396026D | 5 mg 10 mg 25 mg 50 mg 100 mg | $163.00 $204.00 $398.00 $500.00 $714.00 | 1 | |
This compound inhibits glycogen phosphorylase, an enzyme that breaks down glycogen. By inhibiting glycogen degradation, it could indirectly influence glycogenin's role in glycogen synthesis. | ||||||
Alloxan monohydrate | 2244-11-3 | sc-254940 | 10 g | $53.00 | ||
Used in research to induce diabetes in animal models, alloxan can cause massive shifts in glucose and glycogen metabolism, potentially affecting glycogenin activity. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $135.00 $246.00 $619.00 $799.00 $1796.00 | 6 | |
An inhibitor of α-mannosidase II, swainsonine indirectly affects glycosyltransferases involved in N-glycan processing by altering glycan structures in the Golgi apparatus. | ||||||
Kifunensine | 109944-15-2 | sc-201364 sc-201364A sc-201364B sc-201364C | 1 mg 5 mg 10 mg 100 mg | $132.00 $529.00 $1005.00 $6125.00 | 25 | |
A mannosidase I inhibitor, kifunensine can modulate glycosylation patterns by affecting the processing of N-linked glycans, indirectly influencing glycosyltransferase activity. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Known for inhibiting N-linked glycosylation, tunicamycin blocks the first step in the synthesis of dolichol-linked oligosaccharides, thereby indirectly affecting glycosyltransferase activity. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $180.00 $620.00 | 10 | |
This alkaloid acts as an inhibitor of glucosidases, affecting N-linked glycosylation and potentially influencing the overall glycosyltransferase activity. | ||||||
Salubrinal | 405060-95-9 | sc-202332 sc-202332A | 1 mg 5 mg | $33.00 $102.00 | 87 | |
A selective inhibitor of eIF2α dephosphorylation, salubrinal can affect protein folding and glycosylation indirectly, potentially impacting glycosyltransferase functions. | ||||||